MUJHU Research Collaboration

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

Susan E. Dorman, Payam Nahid, Ekaterina V. Kurbatova et al. · New England Journal of Medicine · 2021 · 521 citations · Full text

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

Sinéad Delany‐Moretlwe, James P. Hughes, Peter Bock et al. · The Lancet · 2022 · 498 citations · Full text

Sexual Health, Phase 3, Treatment And Prevention +9

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

Mary Glenn Fowler, Min Qin, Susan A. Fiscus et al. · New England Journal of Medicine · 2016 · 330 citations · Full text

Evaluation of Tuberculosis Diagnostics in Children: 1. Proposed Clinical Case Definitions for Classification of Intrathoracic Tuberculosis Disease. Consensus From an Expert Panel

Stephen M. Graham, Tahmeed Ahmed, Farhana Amanullah et al. · The Journal of Infectious Diseases · 2012 · 324 citations · Full text

Pulmonary Tuberculosis, Expert Panel, Tuberculosis Prevention +15

Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis

Anna Vassall, Sanne van Kampen, Hojoon Sohn et al. · PLoS Medicine · 2011 · 310 citations · Full text